Matassa, Danilo Swann
Criscuolo, Daniela
Avolio, Rosario
Agliarulo, Ilenia
Sarnataro, Daniela
Pacelli, Consiglia
Scrima, Rosella
Colamatteo, Alessandra
Matarese, Giuseppe
Capitanio, Nazzareno
Landriscina, Matteo
Esposito, Franca
Funding for this research was provided by:
Università degli Studi di Napoli Federico II (FRA (Finanziamento della Ricerca di Ateneo) 2020)
Lega Italiana per la Lotta contro i Tumori (LILT grant 5x1000 – 2020)
Regione Campania (POR CAMPANIA FESR 2014/2020 [project “SATIN” (Sviluppo di Approcci Terapeutici INnovativi per patologie neoplastiche resistenti ai trattamenti)])
Article History
Received: 18 August 2022
Accepted: 9 November 2022
First Online: 12 December 2022
Declarations
:
: Patients’ samples were collected under the Imperial College London Tissue Bank project number R15024 (TRAP1 regulates bioenergetics features, cisplatin resistance and epithelial-mesenchymal transition in OC) in accordance with the Imperial College London guidelines. Express written informed consent to use biological specimens for investigational procedures was obtained from all patients. All experimental protocols were approved by Hammersmith and Queen Charlotte’s and Chelsea Research Ethics Committee.
: Not applicable.
: The authors declare that they have no competing interests.